Eastbourne Comments on Election of Directors at Amylin Annual Meeting of Shareholders
May 27 2009 - 2:19PM
Business Wire
Eastbourne Capital Management, L.L.C. announced that, based on
voting estimates from its proxy solicitor, MacKenzie Partners,
Inc., at today�s Annual Meeting of Shareholders at Amylin
Pharmaceuticals, Inc. (NASDAQ: AMLN), it appears that both
Eastbourne and Icahn have succeeded in electing new directors to
the Amylin Board. A preliminary report from the inspectors of
election is expected in one to two weeks.
Richard J. Barry, Eastbourne Founder and Portfolio Manager,
commented, �We want to thank Amylin shareholders for supporting us
in effecting change to the Amylin Board and sending a strong
message that the past results are not acceptable. We look forward
to working constructively with the new Board of Amylin and doing
our part to ensure the long-term success of the Company.�
About Eastbourne Capital Management, L.L.C.
Eastbourne Capital Management is a West Coast-based registered
investment advisor that employs an investment philosophy based on
intensive research, a long-term outlook and a belief in working
alongside portfolio companies to enhance shareholder value.
Amylin Pharmaceuticals, Inc. (MM) (NASDAQ:AMLN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Amylin Pharmaceuticals, Inc. (MM) (NASDAQ:AMLN)
Historical Stock Chart
From Jul 2023 to Jul 2024